Supernus To Present At Two Investor Conferences In September 2012

ROCKVILLE, Md., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced that the company's management will present an overview of the company at the following investor conferences in September:
Stifel Nicolaus 2012 Healthcare Conference
Location: Four Seasons Hotel, Boston, MA
Presentation date: Thursday September 6, 2012
Presentation time: 8:00 a.m. ET
Webcast: http://www.veracast.com/webcasts/stifel/healthcare2012/53201699.cfm
 
Rodman & Renshaw Annual Global Investment Conference 
Location: The Waldorf Astoria, New York, NY 
Presentation date: Monday September 10, 2012 
Presentation time: 3:40 p.m. ET 
Webcast: http://wsw.com/webcast/rrshq22/supn

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company is developing several product candidates in neurology and psychiatry to address large market opportunities in epilepsy and ADHD including ADHD patients with impulsive aggression. These product candidates include Trokendi™ XR (extended-release topiramate), formerly known as SPN-538, and SPN-804 (extended-release oxcarbazepine) for epilepsy, SPN-810 for impulsive aggression in ADHD and SPN-812 for ADHD.
CONTACT: Jack Khattar, President & CEO         Gregory S. Patrick, Vice President and CFO         Supernus Pharmaceuticals, Inc.         Tel: (301) 838-2591

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX